31
Effect of LCZ696 on Urinary Microalbumin and Pulse Wave Velocity in Perimenopausal Patients With Hypertension
Condition(s):HypertensionLast Updated:March 16, 2021Recruiting
Valsartan: 509 Clinical Trials, Page 4 of 51
Hide Studies Not Open or Pending
32
Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
Condition(s):HypertensionLast Updated:January 26, 2016Completed
33
Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation
Condition(s):Atrial Fibrillation Recurrent; HypertensionLast Updated:September 6, 2022Not yet recruiting
34
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers
Condition(s):Healthy; Pharmacokinetics of ValsartanLast Updated:May 27, 2010Completed
35
Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting
Condition(s):Hearth Failure With Reduced Ejection Fraction (HFrEF)Last Updated:June 7, 2019Completed
36
Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy
Condition(s):Hypertension; Left Ventricular HypertrophyLast Updated:August 30, 2011Completed
37
Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.
Condition(s):Heart FailureLast Updated:October 7, 2021Completed
38
The Role of Sacubitril/Valsartan in Post-acute Myocardial Infarction
Condition(s):Acute Myocardial InfarctionLast Updated:October 6, 2022Completed
39
Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure
Condition(s):Heart FailureLast Updated:February 4, 2021Active, not recruiting
40
Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients
Condition(s):First Time Dual Chamber Pacemaker ImplantationLast Updated:January 4, 2017Unknown status